Prescribing Paradigm Shift? Damned If You Do, Damned If You Don't

被引：0
作者：
Marx, Nikolaus [1 ]
Grant, Peter J. [2 ]
机构：
[1] Rhein Westfal TH Aachen, Dept Internal Med Cardiol 1, Aachen, Germany
[2] Univ Leeds, Leeds Inst Cardiovasc & Metab Med, Leeds, W Yorkshire, England
来源：
DIABETES CARE | 2020年 / 43卷 / 09期
关键词：
CARDIOVASCULAR OUTCOMES; EMPAGLIFLOZIN; MORTALITY; DISEASE;
D O I：
10.2337/dci20-0027
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1991 / 1993
页数：3
相关论文
共 19 条
  • [11] Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes
    Nathan, DM
    Cleary, PA
    Backlund, JYC
    Genuth, SM
    Lachin, JM
    Orchard, TJ
    Raskin, P
    Zinman, B
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (25) : 2643 - 2653
  • [12] Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
    Neal, Bruce
    Perkovic, Vlado
    Mahaffey, Kenneth W.
    de Zeeuw, Dick
    Fulcher, Greg
    Erondu, Ngozi
    Shaw, Wayne
    Law, Gordon
    Desai, Mehul
    Matthews, David R.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (07) : 644 - 657
  • [13] Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
    Perkovic, V.
    Jardine, M. J.
    Neal, B.
    Bompoint, S.
    Heerspink, H. J. L.
    Charytan, D. M.
    Edwards, R.
    Agarwal, R.
    Bakris, G.
    Bull, S.
    Cannon, C. P.
    Capuano, G.
    Chu, P. -L.
    De Zeeuw, D.
    Greene, T.
    Levin, A.
    Pollock, C.
    Wheeler, D. C.
    Yavin, Y.
    Zhang, H.
    Zinman, B.
    Meininger, G.
    Brenner, B. M.
    Mahaffey, K. W.
    McGuire, Darren K.
    Holman, Rury
    Home, Philip
    Scharfstein, Dan
    Parfrey, Patrick
    Shahinfar, Shahnaz
    August, Phyllis
    Chang, Tara
    Sinha, Arjun D.
    Januzzi, James
    Kolansky, Daniel
    Amerena, John
    Hillis, Graham
    Gorelick, Philip
    Kissela, Brett
    Kasner, Scott
    Lindley, Richard
    Fulcher, Greg
    Ounadjela, Souhila
    Hufert, Karina
    von Ingersleben, Gabriele
    Gaglia, Jason
    Harris, Ronald
    Hudson, Margo
    Turchin, Alexander
    Cheifetz, Adam
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (24) : 2295 - 2306
  • [14] Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome
    Pfeffer, Marc A.
    Claggett, Brian
    Diaz, Rafael
    Dickstein, Kenneth
    Gerstein, Hertzel C.
    Kober, Lars V.
    Lawson, Francesca C.
    Ping, Lin
    Wei, Xiaodan
    Lewis, Eldrin F.
    Maggioni, Aldo P.
    McMurray, John J. V.
    Probstfield, Jeffrey L.
    Riddle, Matthew C.
    Solomon, Scott D.
    Tardif, Jean-Claude
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (23) : 2247 - 2257
  • [15] Mechanisms by Which Glucagon-Like-Peptide-1 Receptor Agonists and Sodium-Glucose Cotransporter-2 Inhibitors Reduce Cardiovascular Risk in Adults With Type 2 Diabetes Mellitus
    Sharma, Abhinav
    Verma, Subodh
    [J]. CANADIAN JOURNAL OF DIABETES, 2020, 44 (01) : 93 - 102
  • [16] Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)
    Turner, RC
    Holman, RR
    Stratton, IM
    Cull, CA
    Matthews, DR
    Manley, SE
    Frighi, V
    Wright, D
    Neil, A
    Kohner, E
    McElroy, H
    Fox, C
    Hadden, D
    [J]. LANCET, 1998, 352 (9131) : 854 - 865
  • [17] Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
    Turner, RC
    Holman, RR
    Cull, CA
    Stratton, IM
    Matthews, DR
    Frighi, V
    Manley, SE
    Neil, A
    McElroy, K
    Wright, D
    Kohner, E
    Fox, C
    Hadden, D
    Mehta, Z
    Smith, A
    Nugent, Z
    Peto, R
    Adlel, AI
    Mann, JI
    Bassett, PA
    Oakes, SF
    Dornan, TL
    Aldington, S
    Lipinski, H
    Collum, R
    Harrison, K
    MacIntyre, C
    Skinner, S
    Mortemore, A
    Nelson, D
    Cockley, S
    Levien, S
    Bodsworth, L
    Willox, R
    Biggs, T
    Dove, S
    Beattie, E
    Gradwell, M
    Staples, S
    Lam, R
    Taylor, F
    Leung, L
    Carter, RD
    Brownlee, SM
    Fisher, KE
    Islam, K
    Jelfs, R
    Williams, PA
    Williams, FA
    Sutton, PJ
    [J]. LANCET, 1998, 352 (9131) : 837 - 853
  • [18] Wiviott SD, 2019, NEW ENGL J MED, V380, P347, DOI [10.1056/NEJMoa1812389, 10.1056/NEJMc1902837]
  • [19] Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
    Zinman, Bernard
    Wanner, Christoph
    Lachin, John M.
    Fitchett, David
    Bluhmki, Erich
    Hantel, Stefan
    Mattheus, Michaela
    Devins, Theresa
    Johansen, Odd Erik
    Woerle, Hans J.
    Broedl, Uli C.
    Inzucchi, Silvio E.
    Aizenberg, D.
    Ulla, M.
    Waitman, J.
    De Loredo, L.
    Farias, J.
    Fideleff, H.
    Lagrutta, M.
    Maldonado, N.
    Colombo, H.
    Ferre Pacora, F.
    Wasserman, A.
    Maffei, L.
    Lehman, R.
    Selvanayagam, J.
    d'Emden, M.
    Fasching, P.
    Paulweber, B.
    Toplak, H.
    Luger, A.
    Drexel, H.
    Prager, R.
    Schnack, C.
    Schernthaner, G.
    Fliesser-Goerzer, E.
    Kaser, S.
    Scheen, A.
    Van Gaal, L.
    Hollanders, G.
    Kockaerts, Y.
    Capiau, L.
    Chachati, A.
    Persu, A.
    Hermans, M.
    Vantroyen, D.
    Vercammen, C.
    Van de Borne, P.
    Mathieu, C.
    Benhalima, K.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (22) : 2117 - 2128
12